PAPER Gath J, Bousset L, Habenstein B, Melki R, Böckmann A, Meier BH
SEARCH RESULTS
329940 RESULTS
PAPER Kuzdas-Wood D, Stefanova N, Jellinger KA, Seppi K, Schlossmacher MG, Poewe W, Wenning GK
Towards translational therapies for multiple system atrophy.
Prog Neurobiol. 2014 Jul;118:19-35. Epub 2014 Mar 2 PubMed: 24598411PAPER Greene JG
Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson's disease.
Antioxid Redox Signal. 2014 Aug 1;21(4):649-67. Epub 2014 Apr 28 PubMed: 24597973PAPER Wilding C, Bell K, Beck S, Funke S, Pfeiffer N, Grus FH
γ-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway.
PLoS One. 2014;9(3):e90737. Epub 2014 Mar 3 PubMed: 24595072PAPER Garcia-Esparcia P, Llorens F, Carmona M, Ferrer I
Complex Deregulation and Expression of Cytokines and Mediators of the Immune Response in Parkinson's Disease Brain is Region Dependent.
Brain Pathol. 2014 Mar 5; PubMed: 24593806PAPER Schmitt F, Hussain G, Dupuis L, Loeffler JP, Henriques A
A plural role for lipids in motor neuron diseases: energy, signaling and structure.
Front Cell Neurosci. 2014;8:25. Epub 2014 Feb 20 PubMed: 24600344PAPER Haeusler AR, Donnelly CJ, Periz G, Simko EA, Shaw PG, Kim MS, Maragakis NJ, Troncoso JC, Pandey A, Sattler R, Rothstein JD, Wang J
C9orf72 nucleotide repeat structures initiate molecular cascades of disease.
Nature. 2014 Mar 13;507(7491):195-200. Epub 2014 Mar 5 PubMed: 24598541PAPER Koschnitzky JE, Quinlan KA, Lukas TJ, Kajtaz E, Kocevar EJ, Mayers WF, Siddique T, Heckman CJ
Effect of fluoxetine on disease progression in a mouse model of ALS.
J Neurophysiol. 2014 Jun 1;111(11):2164-76. Epub 2014 Mar 5 PubMed: 24598527PAPER Cui Y, Masaki K, Yamasaki R, Imamura S, Suzuki SO, Hayashi S, Sato S, Nagara Y, Kawamura MF, Kira J
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model.
J Neuroinflammation. 2014 Mar 6;11:42. PubMed: 24597481PAPER Kaye WE, Sanchez M, Wu J
Feasibility of creating a National ALS Registry using administrative data in the United States.
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):433-9. Epub 2014 Mar 6 PubMed: 24597459PAPER Carlomagno Y, Zhang Y, Davis M, Lin WL, Cook C, Dunmore J, Tay W, Menkosky K, Cao X, Petrucelli L, Deture M
Casein kinase II induced polymerization of soluble TDP-43 into filaments is inhibited by heat shock proteins.
PLoS One. 2014;9(3):e90452. Epub 2014 Mar 4 PubMed: 24595055PAPER Perera ND, Sheean RK, Scott JW, Kemp BE, Horne MK, Turner BJ
Mutant TDP-43 Deregulates AMPK activation by PP2A in ALS models.
PLoS One. 2014;9(3):e90449. Epub 2014 Mar 4 PubMed: 24595038PAPER Salado IG, Redondo M, Bello ML, Perez C, Liachko NF, Kraemer BC, Miguel L, Lecourtois M, Gil C, Martinez A, Perez DI
Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.
J Med Chem. 2014 Mar 27;57(6):2755-72. Epub 2014 Mar 12 PubMed: 24592867PAPER Debaisieux S, Schiavo G
TiME for TMEM106B.
EMBO J. 2014 Mar 3;33(5):405-6. Epub 2014 Feb 4 PubMed: 24497553PAPER Vladan B, Panfoli I
Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?
Med Hypothesis Discov Innov Ophthalmol. 2012;1(2):24-32. PubMed: 24600616Current Filters
No filters selected